Abstract
Neglected diseases are infectious diseases that affect poor people of tropical countries. Drug resistance, lower availability of funds and research hinder the opportunities for the development of new drugs. The need for new drugs will persist until pathogens are eradicated. This calls for understanding the disease prognosis to initiate research for new drug targets and thus development of new drugs. As drug development is complex and expensive process, in silico drug development can aid in this regard by reducing time, effort and capital for the quest of a “better drug” for such neglected diseases. Recent knowledge about the genome and proteome has increased enthusiasm for the quest of new drug targets. One such potential target can be lipases which are involved in the lipid metabolism of pathogens. Lipases of pathogens have multitude of functions in many patho-physiological processes including virulence, transmission, life cycle development, modulation of host lipids and host immune responses. Thus the aim of this review is to describe the significance of lipases in the life cycle and pathogenesis of the pathogen and whether they can be used as drug targets. The development of research in this direction has also been brought forward. This may help in finding new drug targets for neglected disease.
Keywords: Neglected tropical disease, drug resistance, pathogenecity, lipid metabolism, lipase, drug target.
Current Protein & Peptide Science
Title:Significance of Lipolytic Enzymes in Pathogenesis and Treatment of Neglected Diseases
Volume: 17 Issue: 3
Author(s): Debamitra Chakravorty and Sanjukta Patra
Affiliation:
Keywords: Neglected tropical disease, drug resistance, pathogenecity, lipid metabolism, lipase, drug target.
Abstract: Neglected diseases are infectious diseases that affect poor people of tropical countries. Drug resistance, lower availability of funds and research hinder the opportunities for the development of new drugs. The need for new drugs will persist until pathogens are eradicated. This calls for understanding the disease prognosis to initiate research for new drug targets and thus development of new drugs. As drug development is complex and expensive process, in silico drug development can aid in this regard by reducing time, effort and capital for the quest of a “better drug” for such neglected diseases. Recent knowledge about the genome and proteome has increased enthusiasm for the quest of new drug targets. One such potential target can be lipases which are involved in the lipid metabolism of pathogens. Lipases of pathogens have multitude of functions in many patho-physiological processes including virulence, transmission, life cycle development, modulation of host lipids and host immune responses. Thus the aim of this review is to describe the significance of lipases in the life cycle and pathogenesis of the pathogen and whether they can be used as drug targets. The development of research in this direction has also been brought forward. This may help in finding new drug targets for neglected disease.
Export Options
About this article
Cite this article as:
Chakravorty Debamitra and Patra Sanjukta, Significance of Lipolytic Enzymes in Pathogenesis and Treatment of Neglected Diseases, Current Protein & Peptide Science 2016; 17 (3) . https://dx.doi.org/10.2174/1389203717999160226173614
DOI https://dx.doi.org/10.2174/1389203717999160226173614 |
Print ISSN 1389-2037 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5550 |
Call for Papers in Thematic Issues
Advancements in Proteomic and Peptidomic Approaches in Cancer Immunotherapy: Unveiling the Immune Microenvironment
The scope of this thematic issue centers on the integration of proteomic and peptidomic technologies into the field of cancer immunotherapy, with a particular emphasis on exploring the tumor immune microenvironment. This issue aims to gather contributions that illustrate the application of these advanced methodologies in unveiling the complex interplay ...read more
Artificial Intelligence for Protein Research
Protein research, essential for understanding biological processes and creating therapeutics, faces challenges due to the intricate nature of protein structures and functions. Traditional methods are limited in exploring the vast protein sequence space efficiently. Artificial intelligence (AI) and machine learning (ML) offer promising solutions by improving predictions and speeding up ...read more
Nutrition and Metabolism in Musculoskeletal Diseases
The musculoskeletal system consists mainly of cartilage, bone, muscles, tendons, connective tissue and ligaments. Balanced metabolism is of vital importance for the homeostasis of the musculoskeletal system. A series of musculoskeletal diseases (for example, sarcopenia, osteoporosis) are resulted from the dysregulated metabolism of the musculoskeletal system. Furthermore, metabolic diseases (such ...read more
Protein Folding, Aggregation and Liquid-Liquid Phase Separation
Protein folding, misfolding and aggregation remain one of the main problems of interdisciplinary science not only because many questions are still open, but also because they are important from the point of view of practical application. Protein aggregation and formation of fibrillar structures, for example, is a hallmark of a ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Research Progress of the Types and Preparation Techniques of Scaffold Materials in Cartilage Tissue Engineering
Current Stem Cell Research & Therapy α-Galactosylceramide: Potential Immunomodulatory Activity and Future Application [General Articles]
Current Medicinal Chemistry Substance Abuse and Movement Disorders: Complex Interactions and Comorbidities
Current Drug Abuse Reviews Do Epigenetic Pathways Initiate Late Onset Alzheimer Disease (LOAD): Towards a New Paradigm
Current Alzheimer Research Side Effects of AAS Abuse: An Overview
Mini-Reviews in Medicinal Chemistry Reversal of HIV Drug Resistance and Novel Strategies to Curb HIV Infection: The Viral Infectivity Factor Vif as a Target and Tool of Therapy
Current Drug Targets Epitope Discovery and Their Use in Peptide Based Vaccines
Current Pharmaceutical Design Fibromyalgia
Current Rheumatology Reviews Extracts and Flavonoids of <i>Passiflora</i> Species as Promising Anti-inflammatory and Antioxidant Substances
Current Pharmaceutical Design Bortezomib – First Therapeutic Proteasome Inhibitor for Cancer Therapy: A Review of Patent Literature
Recent Patents on Anti-Cancer Drug Discovery Current Opinion in the Pharmaceutical Management of Irritable and Inflammatory Bowel Diseases: Role of ATP
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Endogeneous Remyelination: Findings in Human Studies
CNS & Neurological Disorders - Drug Targets Pharmacological Countermeasures for the Acute Radiation Syndrome
Current Molecular Pharmacology Glycans and Glycan-Binding Proteins in Brain: Galectin-1-Induced Expression of Neurotrophic Factors in Astrocytes
Current Drug Targets Extracts of Bacopa monnieri (L) Pennell Down-Regulate the Expression of Leukotriene C<sub>4</sub> Synthase mRNA in HL-60 Cells and Suppress OVAInduced Inflammation in BALB/c Mice
Current Bioactive Compounds Peripheral Chemo-Cytokine Profiles in Alzheimers and Parkinsons Diseases
Mini-Reviews in Medicinal Chemistry Cellular and Subcellular Imaging in Live Mice Using Fluorescent Proteins
Current Pharmaceutical Biotechnology Risk for Cervical Intraepithelial Neoplasia in Systemic Lupus Erythematosus is not Related to Disease Severity
Current Rheumatology Reviews Expression of mRNA of Neurotrophic Factors and their Receptors are Significantly Altered After Subchronic Ketamine Treatment
Medicinal Chemistry Recent Advances in Liposomal Drug Delivery: A Review
Pharmaceutical Nanotechnology